CEACAM5 and breast cancer: Similarly, this is the first time to assess, the correlation between serum levels of IL-12, CA and CEA in BC patients; the statistically significant negative correlation reported here confirms the role of IL-12 IL-12 levels in progression of disease as these markers are mainly related to disease progression.